VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis

Journal of Experimental Medicine

Volumn 201, Issue 7, 2005, Pages 1089-1099

  Hirakawa, Satoshi ^a   Kodama, Shohta ^a   Kunstfeld, Rainer ^a   Kajiya, Kentaro ^a,b   Brown, Lawrence F ^c   Detmar, Michael ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ETH ZURICH   (Switzerland)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; VASCULOTROPIN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE TRANSFER; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE; TRANSGENIC MOUSE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GREEN FLUORESCENT PROTEINS; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MICE; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 17144402207     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20041896     Document Type: Article

References (39)

1. Folkman, J. 1992. The role of angiogenesis in tumor growth. Semin. Cancer Biol. 3:65-71.
2. Ferrara, N., H.P. Gerber, and J. LeCouter. 2003. The biology of VEGF and its receptors. Nat. Med. 9:669-676.
3. Skobe, M., T. Hawighorst, D.G. Jackson, R. Prevo, L. Janes, P. Velasco, L. Riccardi, K. Alitalo, K. Claffey, and M. Detmar. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7:192-198.
4. Stacker, S.A., C. Caesar, M.E. Baldwin, G.E. Thornton, R.A. Williams, R. Prevo, D.G. Jackson, S. Nishikawa, H. Kubo, and M.G. Achen. 2001. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7:186-191.
5. Mandriota, S.J., L. Jussila, M. Jeltsch, A. Compagni, D. Baetens, R. Prevo, S. Banerji, J. Huarte, R. Montesano, D.G. Jackson, et al. 2001. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20:672-682.
6. Dadras, S.S., T. Paul, J. Bertoncini, L.F. Brown, A. Muzikansky, D.G. Jackson, U. Ellwanger, C. Garbe, M.C. Mihm, and M. Detmar. 2003. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am. J. Pathol. 162:1951-1960.
7. Alitalo, K., and P. Carmeliet. 2002. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell. 1:219-227.
8. Karpanen, T., M. Egeblad, M.J. Karkkainen, H. Kubo, S. Yla-Herttuala, M. Jaattela, and K. Alitalo. 2001. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61:1786-1790.
9. Skobe, M., L.M. Hamberg, T. Hawighorst, M. Schirner, G.L. Wolf, K. Alitalo, and M. Detmar. 2001. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am. J. Pathol. 159:893-903.
10. Mattila, M.M., J.K. Ruohola, T. Karpanen, D.G. Jackson, K. Alitalo, and P.L. Harkonen. 2002. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int. J. Cancer. 98:946-951.
11. Detmar, M., and S. Hirakawa. 2002. The formation of lymphatic vessels and its importance in the setting of malignancy. J. Exp. Med. 6:713-718.
12. Hirakawa, S., Y.K. Hong, N. Harvey, V. Schacht, K. Matsuda, T. Libermann, and M. Detmar. 2003. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am. J. Pathol. 162:575-586.
13. Hong, Y.K., B. Lange-Asschenfeldt, P. Velasco, S. Hirakawa, R. Kunstfeld, L.F. Brown, P. Bohlen, D.R. Senger, and M. Detmar. 2004. VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J. 18:1111-1113.
14. Makinen, T., T. Veikkola, S. Mustjoki, T. Karpanen, B. Catimel, E.C. Nice, L. Wise, A. Mercer, H. Kowalski, D. Kerjaschki, et al. 2001. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20:4762-4773.
15. Veikkola, T., M. Lohela, K. Ikenberg, T. Makinen, T. Korff, A. Saaristo, T. Petrova, M. Jeltsch, H.G. Augustin, and K. Alitalo. 2003. Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function. FASEB J. 17:2006-2013.
16. Nagy, J.A., E. Vasile, D. Feng, C. Sundberg, L.F. Brown, M.J. Detmar, J.A. Lawitts, L. Benjamin, X. Tan, E.J. Manseau, et al. 2002. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J. Exp. Med. 196:1497-1506.
17. Kriehuber, E., G.S. Breiteneder, M. Groeger, A. Soleiman, S.F. Schoppmann, G. Stingl, D. Kerjaschki, and D. Maurer. 2001. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J. Exp. Med. 194:797-808.
18. Saaristo, A., T. Veikkola, B. Enholm, M. Hytonen, J. Arola, K. Pajusola, P. Turunen, M. Jeltsch, M.J. Karkkainen, D. Kerjaschki, et al. 2002. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J. 16:1041-1049.
19. Kunstfeld, R., S. Hirakawa, Y.K. Hong, V. Schacht, B. Lange-Asschenfeldt, P. Velasco, C. Lin, E. Fiebiger, X. Wei, Y. Wu, et al. 2004. VEGF-A plays a key role in the induction of chronic inflammation and the associated lymphangiogenic response. Blood. 104:1048-1057.
20. Detmar, M., L.F. Brown, M.P. Schön, B.M. Elicker, P. Velasco, L. Richard, D. Fukumura, W. Monsky, K.P. Claffey, and R.K. Jain. 1998. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol. 111:1-6.
21. Yano, K., L.F. Brown, and M. Detmar. 2001. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J. Clin. Invest. 107:409-417.
22. Hawighorst, T., H. Oura, M. Streit, L. Janes, L. Nguyen, L.F. Brown, G. Oliver, D.G. Jackson, and M. Detmar. 2002. Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice. Oncogene. 21:7945-7956.
23. Hawighorst, T., P. Velasco, M. Streit, T.R. Kyriakides, L.F. Brown, P. Bornstein, and M. Detmar. 2001. Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism. EMBO J. 20:2631-2640.
24. Vassar, R., M. Rosenberg, S. Ross, A. Tyner, and E. Fuchs. 1989. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc. Natl. Acad. Sci. USA. 86:1563-1567.
25. Prevo, R., S. Banerji, D.J. Ferguson, S. Clasper, and D.G. Jackson. 2001. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J. Biol. Ckem. 276:19420-19430.
26. Kodama, S., W. Kuhtreiber, S. Fujimura, E.A. Dale, and D.L. Faustman. 2003. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science. 302:1223-1227.
27. Detmar, M., S. Tenorio, U. Hettmannsperger, Z. Ruszczak, and C.E. Orfanos. 1992. Cytokine regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro. J. Invest. Dermatol. 98:147-153.
28. Carmeliet, P. 2003. Angiogenesis in health and disease. Nat. Med. 9:653-660.
29. Dvorak, H.F., L.F. Brown, M. Detmar, and A.M. Dvorak. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146:1029-1039.
30. Ferrara, N. 2002. VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer. 2:795-803.
31. Malik, A.K., and H.P. Gerber. 2003. Targeting VEGF ligands and receptors in cancer. Targets. 2:48-57.
32. Ferrara, N., K.J. Hillan, H.P. Gerber, and W. Novotny. 2004. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat. Rev. Drug Discov. 3:391-400.
33. Banerji, S., J. Ni, S.X. Wang, S. Clasper, J. Su, R. Tammi, M. Jones, and D.G. Jackson. 1999. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144:789-801.
34. Mouta Carreira, C., S.M. Nasser, E. di Tomaso, T.P. Padera, Y. Boucher, S.I. Tomarev, and R.K. Jain. 2001. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res. 61:8079-8084.
35. Oliver, G., and M. Detmar. 2002. The rediscovery of the lymphatic system. Old and new insights into the development and biological function of lymphatic vascular system. Genes Dev. 16:773-783.
36. Leu, A.J., D.A. Berk, A. Lymboussaki, K. Alitalo, and R.K. Jain. 2000. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res. 60:4324-4327.
37. Stacker, S.A., M.G. Achen, L. Jussila, M.E. Baldwin, and K. Alitalo. 2002. Lymphangiogenesis and cancer metastasis. Nat. Rev. Cancer. 2:573-583.
38. Skobe, M., and M. Detmar. 2000. Structure, function and molecular control of the skin lymphatic system. J. Invest. Dermatol. Symp. Proc. 5:14-19.
39. Larcher, F., R. Murillas, M. Bolontrade, C.J. Conri, and J.L. Jorcano. 1998. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene. 17:303-311.